MLTX MLTX

MoonLake Immunotherapeut... Stock Price

7.76
0.00 (0.0%)
7.76
Volume 0
Bid Price 6.19
Ask Price 10.94
News -
Day High

Low
4.25

52 Week Range

High
15.00

Day Low
Company Name Stock Ticker Symbol Market Type
MoonLake Immunotherapeutics MLTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 7.76 04:00:00
Open Price Low Price High Price Close Price Prev Close
7.76
Trades Volume Avg Volume 52 Week Range
0 0 - 4.25 - 15.00
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 7.76 USD

Period:

Draw Mode:

MoonLake Immunotherapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 286.54M 36.93M 10.62M $ - $ - -1.45 -3.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 4.10%

more financials information »

MoonLake Immunotherapeut... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MLTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week7.188.256.93057.557,2820.588.08%
1 Month8.328.606.93057.4719,434-0.56-6.73%
3 Months5.9210.275.137.2753,4251.8431.08%
6 Months12.3715.004.256.8897,498-4.61-37.27%
1 Year12.3715.004.256.8897,498-4.61-37.27%
3 Years12.3715.004.256.8897,498-4.61-37.27%
5 Years12.3715.004.256.8897,498-4.61-37.27%

MoonLake Immunotherapeut... Description

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.


Your Recent History
NASDAQ
MLTX
MoonLake I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now